973 related articles for article (PubMed ID: 17356388)
1. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
2. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
[TBL] [Abstract][Full Text] [Related]
3. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
Avabratha KS; Rau AT; Venkataravanamma P; Rau A
Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
[TBL] [Abstract][Full Text] [Related]
4. Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study.
Chaudhary N; Kosaraju K; Bhat K; Bairy I; Borker A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):617-23. PubMed ID: 22983415
[TBL] [Abstract][Full Text] [Related]
5. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
6. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
[TBL] [Abstract][Full Text] [Related]
7. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of interleukin-5 and monocyte chemotactic protein-1 for bacteremia in children with febrile neutropenia.
Aquino VM; Cost C; Gomez A; Bowers DC; Ramilo O; Ahmad N; Winick N; Leavey PJ
J Pediatr Hematol Oncol; 2012 Aug; 34(6):e241-5. PubMed ID: 22584776
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
10. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation.
Ortega M; Rovira M; Almela M; de la Bellacasa JP; Carreras E; Mensa J
Bone Marrow Transplant; 2004 Apr; 33(7):741-4. PubMed ID: 14730343
[TBL] [Abstract][Full Text] [Related]
11. Role of C-reactive protein velocity in the diagnosis of early bacterial infections in children after cardiac surgery.
Nahum E; Livni G; Schiller O; Bitan S; Ashkenazi S; Dagan O
J Intensive Care Med; 2012; 27(3):191-6. PubMed ID: 21561990
[TBL] [Abstract][Full Text] [Related]
12. IL-8 predicts pediatric oncology patients with febrile neutropenia at low risk for bacteremia.
Cost CR; Stegner MM; Leonard D; Leavey P
J Pediatr Hematol Oncol; 2013 Apr; 35(3):206-11. PubMed ID: 23425997
[TBL] [Abstract][Full Text] [Related]
13. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
Baskaran ND; Gan GG; Adeeba K
Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
[TBL] [Abstract][Full Text] [Related]
15. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
16. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropenia.
Tromp YH; Daenen SM; Sluiter WJ; Vellenga E
Eur J Cancer; 2009 Mar; 45(4):596-600. PubMed ID: 19095436
[TBL] [Abstract][Full Text] [Related]
18. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
[TBL] [Abstract][Full Text] [Related]
19. Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study.
Offidani M; Corvatta L; Malerba L; Marconi M; Bichisecchi E; Cecchini S; Manso E; Principi T; Gasparini S; Leoni P
Cancer; 2004 Aug; 101(3):567-77. PubMed ID: 15274070
[TBL] [Abstract][Full Text] [Related]
20. Serum derivative of reactive oxygen metabolites (d-ROMs) in pediatric hemato-oncological patients with neutropenic fever.
Nishikawa T; Okamoto Y; Kodama Y; Tanabe T; Shinkoda Y; Kawano Y
Pediatr Blood Cancer; 2010 Jul; 55(1):91-4. PubMed ID: 20486174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
